Borderline HER‐2 breast cancer cases: Histochemical versus real‐time PCR analysis and impact of different cut‐off values (Q58005897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Borderline HER-2 breast cancer cases: histochemical versus real-time PCR analysis and impact of different cut-off values (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Monego G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Arena V

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Maggiano N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Costarelli L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Zelano G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Amini M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Capelli A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Carbone A

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Clinical and Laboratory Investigation

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

402-412

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

The clinical evaluation of HER-2 status: which test to use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Best Practice No 176: Updated recommendations for HER2 testing in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Testing for HER2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Current diagnostic methods of HER-2/neu detection in breast cancer with special regard to real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Comparative multi-methodological measurement of ERBB2 status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast can

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Assessment of thin-layer breast aspirates for immunocytochemical evaluation of HER2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

Clinical cardiac tolerability of trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365510601128934

10.1080/00365510601128934

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17558895%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference